EUVIMEDEUVIMED entdecken
Crossref

Use of atomoxetine in children and adolescents with ADHD

Somnath Banerjee

Progress in Neurology and Psychiatry · 2009

DOI: 10.1002/pnp.114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Progress in Neurology and Psychiatry, 2009. Verfasst von Somnath Banerjee. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atomoxetine is a non‐stimulant drug licensed for use in the treatment of attention deficit‐hyperactivity disorder (ADHD).Dr Banerjee describes a study that was carried out over a two‐year period in the three ADHD clinics in East Kent Hospitals NHS Trust to evaluate the current practice on the use of atomoxetine in ADHD in children and adolescents. Copyright © 2009 Wiley Interface Ltd

Zitieren

APA

Banerjee, S. (2009). Use of atomoxetine in children and adolescents with ADHD. Progress in Neurology and Psychiatry. https://doi.org/10.1002/pnp.114

Vancouver

Banerjee S. Use of atomoxetine in children and adolescents with ADHD. Progress in Neurology and Psychiatry. 2009. doi:10.1002/pnp.114

BibTeX
@article{Banerjee2009,
  author = {Banerjee, Somnath},
  title = {Use of atomoxetine in children and adolescents with ADHD},
  journal = {Progress in Neurology and Psychiatry},
  year = {2009},
  doi = {10.1002/pnp.114}
}
Kostenlos starten →